St. John's Wort Dosing for Moderate Depression
For moderate depression, use St. John's wort standardized extract (0.3% hypericin) at 900 mg daily, divided into three doses of 300 mg each, with the option to increase to 1200-1500 mg daily if inadequate response after 4 weeks.
Evidence-Based Dosing Regimen
The guideline evidence from the American College of Physicians systematic review 1 demonstrates that clinical trials used dosages ranging from 300 mg/day to 1800 mg/day, with most trials using standardized extracts containing 0.12% to 0.28% hypericin. The most commonly studied and effective regimen is:
- Starting dose: 300 mg three times daily (900 mg/day total) 2
- Titration: If inadequate response after 4 weeks, increase to 1200-1500 mg daily 3
- Severe depression alternative: 600 mg three times daily (1800 mg/day) may be needed for more severe cases 2
Clinical Efficacy Evidence
The ACP guideline meta-analysis of 9 trials with 1513 participants 1 showed St. John's wort achieved similar response rates to second-generation antidepressants (54% vs 52%) after 6-12 weeks of treatment. Importantly, St. John's wort had significantly lower discontinuation rates due to adverse events (4% vs 7%) compared to standard antidepressants 1.
A 2017 meta-analysis of 27 trials with 3808 patients 4 confirmed comparable efficacy to SSRIs with significantly lower dropout rates (pooled OR 0.587, p<0.001).
Treatment Duration and Monitoring
- Initial trial period: 6-8 weeks to assess response 1, 3, 5
- Response definition: At least 50% reduction in depression rating scale scores
- Continuation: Responders at 8 weeks can continue treatment for an additional 18 weeks 3
Critical Safety Considerations
Major drug interaction warning: St. John's wort induces cytochrome P450 enzymes and P-glycoprotein 6, causing clinically significant interactions with:
- Oral contraceptives
- Anticoagulants (warfarin)
- Immunosuppressants
- HIV medications
- Many other prescription drugs
This is why the expanded question specifically excludes patients on interacting medications—this is a non-negotiable contraindication that must be verified before prescribing.
Practical Implementation
- Confirm no drug interactions before initiating therapy
- Start with 300 mg three times daily (standardized to 0.3% hypericin)
- Assess response at 4 weeks—if inadequate improvement, increase to 1200 mg daily
- Continue for minimum 6-8 weeks before determining efficacy
- Monitor for adverse effects (though these are generally mild: headache being most common at 41% vs 25% placebo) 7
Evidence Quality Considerations
While the 2023 ACP guideline 8 notes that certainty of evidence is low for most comparisons due to methodological limitations and small sample sizes, the consistent finding across multiple trials is that St. John's wort demonstrates efficacy comparable to standard antidepressants with a superior tolerability profile 1, 4. The main limitation noted is that many comparison trials used suboptimal doses of comparator antidepressants 1, though this actually strengthens confidence in St. John's wort's relative safety profile.
The evidence supports St. John's wort as a viable first-line option for moderate depression when drug interactions are absent, with the standard 900 mg/day dosing providing the best balance of efficacy and tolerability.